Alana Sine, CPA

Chief Financial Officer, Merz North America

Professional Overview
Alana Sine is an accomplished finance executive with extensive experience in the pharmaceutical industry. As the Chief Financial Officer at Merz North America, she oversees all financial operations, reporting, and strategic decision-making for the company's North American business. With her deep expertise in financial reporting, planning, and compliance, Alana has played a pivotal role in driving the organization's financial performance and growth.

Experience Summary

Current Role
Alana currently serves as the Chief Financial Officer at Merz North America, a role she has held since June 2018. In this capacity, she is responsible for managing the company's financial operations, including budgeting, forecasting, and regulatory compliance. Under her leadership, Alana has implemented streamlined financial processes and systems, improving the company's overall financial visibility and decision-making capabilities. Additionally, she has played a crucial role in aligning the company's financial strategy with its broader business objectives, contributing to Merz's continued growth and expansion in the North American market.

Career Progression
Prior to her current role, Alana held various financial positions within Merz North America, including serving as the Interim Chief Financial Officer and the Senior Director of Financial Reporting. She joined the company in 2013 as the Director of Financial Reporting, where she was instrumental in enhancing the company's financial reporting and compliance practices. Before joining Merz, Alana gained valuable experience as a Senior Audit Associate at Ernst & Young and a Senior Accountant at Lowes Foods.

Academic Background
Alana holds a Bachelor of Science degree in Accounting from the University of North Carolina at Chapel Hill. She is a Certified Public Accountant (CPA) and has demonstrated a strong commitment to ongoing professional development, ensuring her skills and knowledge remain aligned with industry best practices.

Areas of Expertise

• Financial reporting and analysis

• Budgeting and forecasting

• Financial planning and strategy

• Regulatory compliance

• Financial process optimization

• Cross-functional collaboration

• Team leadership and management

Professional Impact
During her tenure at Merz North America, Alana has played a pivotal role in strengthening the company's financial position and supporting its strategic growth initiatives. Some of her key achievements include:

• Implemented a new financial reporting system, which improved data accuracy and streamlined reporting processes, resulting in a 20% reduction in monthly close times.

• Spearheaded the development of a comprehensive financial planning and analysis framework, enabling the executive team to make more informed, data-driven decisions.

• Led the successful integration of financial operations following the acquisition of a major competitor, ensuring a seamless transition and minimal disruption to the business.

• Actively contributed to the company's expansion strategy, providing financial insights and recommendations that supported the successful launch of new products in the North American market.

Conclusion
With her exceptional financial acumen, strategic mindset, and proven track record of delivering results, Alana Sine is a dynamic and influential leader within the pharmaceutical industry. As the Chief Financial Officer at Merz North America, she continues to drive the company's financial performance and support its overall growth and success.